87 related articles for article (PubMed ID: 28290042)
41. Development of a topical polymeric mucoadhesive ocular delivery system for azithromycin.
Bowman LM; Si E; Pang J; Archibald R; Friedlaender M
J Ocul Pharmacol Ther; 2009 Apr; 25(2):133-9. PubMed ID: 19284320
[TBL] [Abstract][Full Text] [Related]
42. Preparation of microparticles of naproxen with Eudragit RS and talc by spherical crystallization technique.
Maghsoodi M; Esfahani M
Pharm Dev Technol; 2009; 14(4):442-50. PubMed ID: 19235551
[TBL] [Abstract][Full Text] [Related]
43. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
Ibekwe VC; Fadda HM; Parsons GE; Basit AW
Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
[TBL] [Abstract][Full Text] [Related]
44. Long-term studies on the stability and oral bioavailability of cyclosporine A nanoparticle colloid.
Wang XQ; Huang J; Dai JD; Zhang T; Lü WL; Zhang H; Zhang X; Wang JC; Zhang Q
Int J Pharm; 2006 Sep; 322(1-2):146-53. PubMed ID: 16787721
[TBL] [Abstract][Full Text] [Related]
45. Drying of crystalline drug nanosuspensions-the importance of surface hydrophobicity on dissolution behavior upon redispersion.
Van Eerdenbrugh B; Froyen L; Van Humbeeck J; Martens JA; Augustijns P; Van den Mooter G
Eur J Pharm Sci; 2008 Sep; 35(1-2):127-35. PubMed ID: 18644441
[TBL] [Abstract][Full Text] [Related]
46. Preparation and characterization of metformin hydrochloride loaded-Eudragit®RSPO and Eudragit®RSPO/PLGA nanoparticles.
Cetin M; Atila A; Sahin S; Vural I
Pharm Dev Technol; 2013; 18(3):570-6. PubMed ID: 21864098
[TBL] [Abstract][Full Text] [Related]
47. Self assembling nanostructures for sustained ophthalmic drug delivery.
Khopade AJ; Jain NK
Pharmazie; 1995 Dec; 50(12):812-4. PubMed ID: 8584558
[TBL] [Abstract][Full Text] [Related]
48. Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations.
Nath B; Nath LK; Kumar P
Acta Pol Pharm; 2011; 68(3):409-15. PubMed ID: 21648196
[TBL] [Abstract][Full Text] [Related]
49. Development of etoposide-loaded bovine serum albumin nanosuspensions for parenteral delivery.
Wang Z; Li Z; Zhang D; Miao L; Huang G
Drug Deliv; 2015 Jan; 22(1):79-85. PubMed ID: 24401038
[TBL] [Abstract][Full Text] [Related]
50. Development of a biodegradable nanoparticle platform for sildenafil: formulation optimization by factorial design analysis combined with application of charge-modified branched polyesters.
Beck-Broichsitter M; Schmehl T; Gessler T; Seeger W; Kissel T
J Control Release; 2012 Feb; 157(3):469-77. PubMed ID: 21930166
[TBL] [Abstract][Full Text] [Related]
51. Preparation and characterization of nebivolol nanoparticles using Eudragit® RS100.
Jana U; Mohanty AK; Manna PK; Mohanta GP
Colloids Surf B Biointerfaces; 2014 Jan; 113():269-75. PubMed ID: 24140793
[TBL] [Abstract][Full Text] [Related]
52. Clotrimazole-loaded Eudragit® RS100 nanocapsules: preparation, characterization and in vitro evaluation of antifungal activity against Candida species.
Santos SS; Lorenzoni A; Ferreira LM; Mattiazzi J; Adams AI; Denardi LB; Alves SH; Schaffazick SR; Cruz L
Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1389-94. PubMed ID: 23827586
[TBL] [Abstract][Full Text] [Related]
53. Process and formulation variables of pregabalin microspheres prepared by w/o/o double emulsion solvent diffusion method and their clinical application by animal modeling studies.
Aydogan E; Comoglu T; Pehlivanoglu B; Dogan M; Comoglu S; Dogan A; Basci N
Drug Dev Ind Pharm; 2015; 41(8):1311-20. PubMed ID: 25119000
[TBL] [Abstract][Full Text] [Related]
54. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L
Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552
[TBL] [Abstract][Full Text] [Related]
55. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
Zhang X; Zhang T; Lan Y; Wu B; Shi Z
AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778
[TBL] [Abstract][Full Text] [Related]
56. Influence of ibuprofen as a solid-state plasticizer in Eudragit RS 30 D on the physicochemical properties of coated beads.
Wu C; McGinity JW
AAPS PharmSciTech; 2001 Nov; 2(4):24. PubMed ID: 14727861
[TBL] [Abstract][Full Text] [Related]
57. Development of Lyophilised Eudragit
Lombardo R; Ruponen M; Rautio J; Ghelardini C; Di Cesare Mannelli L; Calosi L; Bani D; Lampinen R; Kanninen KM; Koivisto AM; Penttilä E; Löppönen H; Pignatello R
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242796
[TBL] [Abstract][Full Text] [Related]
58. Ocular insert for sustained delivery of gatifloxacin sesquihydrate: Preparation and evaluations.
Khurana G; Arora S; Pawar PK
Int J Pharm Investig; 2012 Apr; 2(2):70-7. PubMed ID: 23119235
[TBL] [Abstract][Full Text] [Related]
59. Polymethyacrylate based microparticulates of insulin for oral delivery: preparation and in vitro dissolution stability in the presence of enzyme inhibitors.
Agarwal V; Reddy IK; Khan MA
Int J Pharm; 2001 Aug; 225(1-2):31-9. PubMed ID: 11489552
[TBL] [Abstract][Full Text] [Related]
60. Design and Characterization of Ocular Inserts Loaded with Dexamethasone for the Treatment of Inflammatory Ophthalmic Disease.
Guadarrama-Escobar OR; Valdés-Alvarez CA; Constantino-Gonzalez KS; Serrano-Castañeda P; Peña-Juárez MC; Morales-Florido MI; Salgado-Machuca M; Rodríguez-Pérez B; Rodriguez-Cruz IM; Vargas-Estrada D; Mercado-Márquez C; Vázquez-Durán A; Méndez-Albores A; Anguíano-Almazán E; Escobar-Chavez JJ
Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
